Day: April 21, 2021

Verizon reports strong start to 2021 as company accelerates 5G growth

Written by Customer Service on April 21, 2021. Posted in Earnings Releases And Operating Results.

Strong financial and operational performance highlighted by growth in wireless service revenue, wireless equipment revenue and total Fios Internet net additions 1Q 2021 highlights Consolidated:$1.27 in earnings per share (EPS), compared with $1.00 in 1Q 2020; adjusted EPS (non-GAAP), excluding a special item, of $1.31, compared with $1.26 in 1Q 2020. Operating revenue increase of 4.0 percent from first-quarter 2020. Net income of $5.4 billion, an increase of 25.4 percent from first-quarter 2020, and adjusted EBITDA (non-GAAP) of $12.2 billion, an increase from $11.9 billion in first-quarter 2020.Consumer:Total revenue of $22.8 billion, an increase of 4.7 percent year over year. 326,000 retail postpaid net losses, including 225,000 phone net losses. Total retail postpaid churn of 0.97 percent, and retail postpaid phone churn of 0.77...

Navios Maritime Holdings Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020

Written by Customer Service on April 21, 2021. Posted in Earnings Releases And Operating Results.

MONACO, April 21, 2021 (GLOBE NEWSWIRE) — Revenue$416.7 million for FY 2020 $102.4 million for Q4 2020Cash provided by/(used in) operating activities$25.2 million for FY 2020 $(10.1) million for Q4 2020Adjusted EBITDA$153.4 million for FY 2020 $37.6 million for Q4 2020Navios PartnersCompleted merger with Navios Containers on March 31, 2021 Post-merger: NM owns 12.6%$36.2 million debt reduction in Q1 2021 Navios Maritime Holdings Inc. (“Navios Holdings” or “the Company”) (NYSE: NM), a global seaborne shipping and logistics company, today reported financial results for the fourth quarter and year ended December 31, 2020. Angeliki Frangou, Chairman and Chief Executive Officer, stated, “I am pleased with the results for the fourth quarter and full year of 2020. For the full year of 2020, Navios Holdings reported revenue...

Form 8.3 – Aggreko Plc (Amended)

Written by Customer Service on April 21, 2021. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)AMENDMENT CHANGE TO SECTION 2A 1. KEY INFORMATION(a) Full name of discloser: Rathbone Brothers PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Aggreko Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For...

Medical Coatings Market to Hit USD 7,990.0 Million by 2027; Growing Number of Minimally Invasive Procedures to Spur Business Opportunities, Says Fortune Business Insights™

Written by Customer Service on April 21, 2021. Posted in Mergers And Acquisitions.

Pune, India, April 21, 2021 (GLOBE NEWSWIRE) — The global medical coatings market size is expected to reach USD 7,990.0 million by 2027, exhibiting a CAGR of 9.7% during the forecast period. The increasing preference for antimicrobial coatings over disinfectants and other cleaning agents will enable speedy expansion of the market, states Fortune Business Insights, in a report, titled “Medical Coatings Market Size, Share & COVID-19 Impact Analysis, By Type (Hydrophilic Coatings, Anti-microbial Coatings, Anti-thrombogenic Coatings, and Others), By Material Type (Fluoropolymer, Silicone, Parylene, Metals, and Others), By Application (Medical Device, Medical Implants, Medical Equipment & Tools, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 3,690.0 million in 2019. List of the Leading Companies...

Cerevel Therapeutics Appoints Abraham N. Ceesay as President

Written by Customer Service on April 21, 2021. Posted in Public Companies.

CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced the appointment of Abraham N. Ceesay to the newly-created role of president, effective May 3, 2021. Mr. Ceesay brings nearly two decades of healthcare experience leading operations at a number of biopharmaceutical companies, serving most recently as chief executive officer at Tiburio Therapeutics, a privately-held biotechnology company. As president, he will be responsible for developing Cerevel’s commercial capabilities and infrastructure and will oversee corporate strategy, business development, and portfolio and program management. “Abe brings tremendous experience and a strong track record in building outstanding commercial organizations. His strategic...

Apellis Pharmaceuticals to Hold First Quarter 2021 Earnings Conference Call on April 28, 2021

Written by Customer Service on April 21, 2021. Posted in Public Companies.

WALTHAM, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its first quarter 2021 financial results on Wednesday, April 28, 2021 at 4:30 p.m. ET. The event will be available live by dialing (866) 774-0323 (domestic) or (602) 563-8683 (international) and entering the conference ID # 7883183 or via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event. About ApellisApellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging...

REGO Payment Architectures, Inc. Unveils Payment Platform Allowing Minors to Transact on Merchant Sites that Present MazoolaPay

Written by Customer Service on April 21, 2021. Posted in Public Companies.

MazoolaPaySM offers an unrivaled all-digital, two-sided payment platform experience for children BLUE BELL, Pa., April 21, 2021 (GLOBE NEWSWIRE) — REGO Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), provider of an all digital-based service allowing children to make purchases anytime, from anywhere using their mobile devices, today announced MazoolaPaySM, a two-sided payment solution that connects merchants, financial partners and consumers through a COPPA (Children’s Online Privacy Protection Act) and GDPR (General Data Protection Regulation) compliant payment platform. Merchants are enabled to directly transact with children while maintaining privacy and consent compliance. Children can transact on-line or in-store, everywhere MazoolaPaySM is presented. “This engineering achievement democratizes privacy, security and guardian-defined...

Harbor Custom Development, Inc. Contracts to Acquire 106 Lots for $16,900,000 Expanding Austin Metro Housing Footprint

Written by Customer Service on April 21, 2021. Posted in Public Companies.

Gig Harbor, Washington , April 21, 2021 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes®,” or the “Company”), (NASDAQ:HCDI), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced that it has contracted to acquire 106 developed single family lots for $16,900,000 in the Summit Rock Golf Course community in Horseshoe Bay, Texas, located approximately 53 miles west of Austin. Harbor Custom Homes® anticipates commencing construction of 4- and 5-bedroom homes on lots ranging from 0.25 to 1.50 acres and expected to be priced from $800,000 to $1,200,000 in the Summit Rock Golf Course community beginning in the third quarter of 2021. Summit Rock has been featured as one of Golfweek’s Top 100 courses in the U.S. (https://hsbresortrealty.com/resort_development/summit-rock/)...

Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation Forum

Written by Customer Service on April 21, 2021. Posted in Public Companies.

CHATHAM, N.J., April 21, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, was invited to deliver a company presentation and participate in a panel at the 4th Annual Neuroscience Innovation Forum for Business Development, Licensing and Investment, hosted by Sachs Associates and taking place from April 28-30, 2021. Virtual Panel Details Title: Pain, Migraine & AddictionDate: Thursday, April 29, 2021Time: 11:45 a.m. – 12:45 p.m. ET The Company’s presentation will be available on demand during the conference to registered conference participants through the Sachs Associates conference website. The presentation will be available subsequent to the conference...

Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum

Written by Customer Service on April 21, 2021. Posted in Public Companies.

BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a virtual panel discussion at the Sachs 4th Annual Neuroscience Innovation Forum. The panel, titled “Progress in Alzheimer’s and Dementia,” will be aired on Wednesday, April 28, 2021, at 8:30 a.m. PT /11:30 a.m. ET. The panel will be moderated by Howard Fillit, M.D., Founding Executive Director at the Alzheimer’s Drug Discovery Foundation, and Paul Matteis, Managing Director at Stifel, and will include a discussion with the following participants:David Elmaleh, Ph.D., Chairman and Chief Scientific Officer,...

Day: April 21, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals